Status: Recruiting
Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds
The aim of this post market clinical follow up (PMCF) study is to confirm the performance of Debrisoft® Duo, to collect safety data regarding expected adverse events and to detect potential unexpected adverse events associated with the use of Debrisoft® Duo within the certified indications and under the conditions of routine use.
Participants needed: 104
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Lohmann & RauscherUpdated: Dec 31, 2025Locations: 5
Eligibility criteria
Age ≥ 18 years [+15]
Known allergy and/or hypersensitivity to Debrisoft® Duo or any of the product co... [+10]